Tempus AI surges on Q3 beats, raised revenue guidance
Tempus AI (TEM) shares rose 11% after Q3 results exceeded expectations and the company increased its 2026 revenue forecast to $1.60B-$1.605B, up from $1.595B-$1.605B. Adjusted EBITDA guidance remains at ~$65M.
How this was made
The 30-second read
Why it matters
The earnings beat and raised guidance suggest strong demand for its services, supporting a bullish outlook.
Market read
The surprise earnings and guidance lift are likely to attract short-term buying interest.
What to watch
Potential margin pressure despite revenue growth; macro AI spending trends.
Background
Tempus AI is a provider of AI-driven clinical data platforms, recently listed on NASDAQ.
Ticker impact
Tempus AI reported Q3 earnings beat and raised its 2026 revenue guidance to $1.60B-$1.605B.
likely upside as market prices in the earnings beat and raised guidance
The company posted better-than-expected results and increased revenue outlook, prompting an 11% price jump.
Market effects
AI and data analytics sector may see broader optimism from the beat.
U.S. tech market could receive a modest lift.
Limited to investors tracking AI-driven companies.
Counterpoint
If guidance falls short of analyst expectations later, the rally could reverse.
Key entities
- companyTempus AI
AI-driven clinical data platform provider
